AI GxP validation for regulated life sciences
AI Governance

The White House SI Accord: What "Internal Controls and Layers of Audits" Actually Means

The industry accord signed alongside the order is voluntary and, in the President's words, morally binding. What its commitments would mean if taken seriously, and how they compare with what GMP has required of computerised systems for decades.

Cybroscape Technologies5 min read

Key takeaway

The industry accord signed alongside the order is voluntary and, in the President's words, morally binding. What its commitments would mean if taken seriously, and how they compare with what GMP has required of computerised systems for decades.

Alongside the executive order, a group of technology chief executives signed a voluntary accord on Super Intelligence at the White House. It commits signatories to robust internal controls and multiple layers of audits and reviews. The President described it as "morally binding" rather than legally enforceable.

For anyone who works in GMP, the commitments will read oddly — not because they are wrong, but because they describe controls that regulated manufacturing has treated as table stakes for about thirty years.

What the accord commits to

The published commitments centre on internal controls and layered audit and review of how these systems are developed and deployed. It is a principles statement setting expectations, not a rulebook with obligations and penalties.

Two honest observations. It is voluntary, so there is no enforcement mechanism and no consequence for a signatory that quietly does less. And it binds the developers of these systems, not the companies deploying them — so it changes nothing about what you must do when you put a model into a GMP process.

It is still worth reading, for a reason that has nothing to do with compliance: it tells you what the largest model providers are willing to say in public about their own controls, which is useful when you are assessing one as a supplier.

GMP got there first

Strip the accord down and the principles are ones a quality professional could have written: keep documented internal controls, have independent review, audit what you build, keep records of it.

Regulated manufacturing has required exactly that of computerised systems since long before machine learning was a commercial proposition. Independent QA review, segregation of duties, tamper-evident audit trails, periodic review, change control, and a named person accountable for a decision — see GxP roles and responsibilities.

There is a reasonable point of pride here for people who work in this industry. The governance model the technology sector is now committing to voluntarily is a weaker version of what GMP has enforced for decades — and where the two meet, in the draft Annex 22, the regulated version is far more specific about what human oversight actually requires.

How to use it in a supplier assessment

If a vendor cites the accord in a sales conversation, treat the citation as a starting point rather than evidence, and ask what it means for you specifically:

  • "You signed the accord. Which internal controls does that translate into for the product I would buy?"
  • "Who performs the audits and reviews, and can I see a report?"
  • "Does it change my contract in any way?" — almost certainly not, since the accord is voluntary and the contract is what binds anyone.
  • "How does it affect the things I actually need: version pinning, change notification, data handling?" See qualifying an AI vendor.

A signature on a voluntary accord is not a qualification record, and it does not satisfy your supplier assessment. What satisfies it is evidence — see supplier qualification.

Broader picture in what the rename changes for GxP and GxP AI.

Where to go next

Explore Cybroscape GxP Copilot for AI-native validation, Cybroscape TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.

US federal writingSuper Intelligence (SI)The term federal agencies now use
What does not change
  • Intended use defined and bounded
  • Validated before GxP use
  • Data integrity (ALCOA+)
  • A person decides what matters
  • Changes go through change control
EU GMP · Annex 22 · EU AI Act · MHRAArtificial intelligence (AI)The term in EU and UK rules
One quality systemTwo vocabularies, one set of controls
The US federal rename changes the word, not the obligations. EU GMP, the draft Annex 22, the EU AI Act and MHRA still say artificial intelligence, and the validation work is the same under either name.
See it on your own systemBring a URS or a system. We run GxP Copilot against it live on the call.

Sources

Primary documents referred to on this page, from their official publishers.

white house si accordsuperintelligence accordsi accord commitmentsvoluntary ai commitments pharma
FAQ

Frequently Asked Questions

Prefer to talk first? Chat with us on WhatsApp or book a call with an expert.

What is the White House SI accord?

A voluntary accord signed by a group of technology chief executives alongside the 29 September 2026 executive order. It commits signatories to robust internal controls and multiple layers of audits and reviews. The President described it as 'morally binding' rather than legally enforceable.

Does the accord create obligations for pharma companies?

No. It is voluntary, has no enforcement mechanism, and binds the developers of these systems rather than the companies deploying them. It changes nothing about what you must do when you put a model into a GMP process.

How do the accord's commitments compare with GMP?

They are a weaker version of controls regulated manufacturing has required of computerised systems for decades: documented internal controls, independent review, audit trails, periodic review, change control and a named accountable person. The draft Annex 22 is far more specific about what human oversight requires.

A vendor cites the accord in their pitch. What should we ask?

Which internal controls it translates into for the product you would buy; who performs the audits and reviews and whether you can see a report; whether it changes your contract, which it almost certainly does not; and how it affects version pinning, change notification and data handling.

Is signing the accord a supplier qualification?

No. A signature on a voluntary accord is not a qualification record and does not satisfy a supplier assessment. What satisfies it is evidence you have examined.

Keep reading

All articles
AI GovernanceCan You Use Microsoft Copilot or ChatGPT in a GxP Environment?The question every quality team is being asked. Where general-purpose AI assistants are fine in a regulated company, where they are not, why they cannot produce Part 11 records, and how to write a policy people will follow. · 7 min readAI GovernanceAI for Deviation Investigations and CAPA: What Works and What Doesn'tWhere AI genuinely helps with deviations and CAPA (triage, similar-case retrieval, drafting), what must stay a human decision under GMP, and the failure mode that quietly reinforces bad root causes. · 6 min readAI GovernanceAI governance for Life Sciences: the operating model that actually shipsPolicies, model registry, use-case intake, HITL policy, drift, red-teaming: engineered for regulated environments. · 6 min readAI GovernanceAI in Pharmacovigilance: Case Processing and Signal DetectionPV volumes grow every year and headcount does not. Where AI genuinely helps with intake, coding and triage, why signal detection is harder than it looks, and the causality judgement that cannot be delegated. · 5 min readAI GovernanceAI in the QC Lab: Where It Helps and Where It Must Not DecideChromatography review, OOS triage, stability trending and method transfer are the lab's slowest work. What AI can genuinely take on, what has to stay an analyst's call, and why lab data integrity history makes this area sensitive. · 6 min readAI GovernanceFour factors for judging AI risk in GMP: uncertainty, complexity, model influence, detectabilityA severity score where everything comes out high changes nothing. The four considerations EMA's workshop report names produce a more honest assessment. · 7 min readAI GovernanceThe EU AI Act and life sciences: less than you fear, plus one thing you missedMost GxP AI is not high-risk under the EU AI Act. Medical device AI and AI used in hiring or performance decisions are, and the AI literacy duty has applied to every company using AI since February 2025. · 3 min readAI GovernanceWhy Quality Teams Resist AI, and What Actually Changes Their MindsThe resistance is usually rational, and treating it as a training problem makes it worse. What quality professionals are actually objecting to, which arguments land, and the one demonstration that moves people. · 6 min read

Bring a system. We'll show you the package.

Book a demo, or ask a validation lead a quick question on WhatsApp.

  • We reply within one business day
  • We run your URS live on the call
  • You get a clear plan for your system
Chat on WhatsApp

Book a demo

Four fields. The right specialist replies within one business day.

Your details stay private. We never share them.